DOI:

Self-promotional, or taking the lead?

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

As we all know, there is a fine line between self-promotion – showing off – and challenging others to greater achievements. We face this dilemma often in our professional and personal lives: the professor wanting to spur on his students to a better understanding; the parent, gently seeking to inspire their children; the trainer pushing on his athletes... We have learned to live by – and evolve – through challenges and healthy competition. Certainly there are dangers, self-delusions, faulty communications involved, and, yes, it is a tightrope act, but we believe one worth attempting, because without setting a standard in the first place, without throwing that first rock in the pond and causing ripples, we might not know there was water there to begin with. Putting out our own work for others to react to, either for praise, criticism or indifference... at least creates a reaction and gives us something to build upon.

So what are we doing here? As you look through this upcoming issue you will see several articles from Rotterdam, as well as others online as “ahead-of-print”. There are such articles as “Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement” by Amber M Otten, or the late-breaking “Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation CoreValve ReValving system, results from the multicentre, expanded evaluation registry 1-year following CE mark approval” by Nicolo Piazza. There is the return of our “hands-on” educational section “How should I treat” with a case presented by Peter de Jaegere – though here I should point out that we have invited commentary by an interventionalist and surgeon from the renowned Heart Centre, Leipzig, Germany.

So are we, in doing this, showing off the work of our own centre, or are we, in fact, merely spotlighting the wealth of information that has been produced here in the Netherlands these past few years? We have been advancing aggressively with research and developments in structural heart disease, which, by the way, is an important theme in this current issue of EuroIntervention. Valve replacement itself was a buzzword at the last EuroPCR in Barcelona. There is a feeling of excitement and real achievements in what is now happening in our field, and while I know that we are not the only ones working in this specific area, you will often see our work on this subject in other journals – so why not publish in Europe’s only interventional journal? Create the dialogue. Move things, not necessarily in our direction alone, but knowing that we need to begin somewhere, and we know where we are... If nothing else.

This is not, nor is meant to be, a journal reflecting one point-of-view, whether institutional, cultural or scientific. We encourage an active and constructive debate as can be seen the following editorials by surgeons, and the wealth of other material drawn from throughout the world. We know our efforts are not going unnoticed as well. At EuroPCR, many participants responding to an in-house poll, read our journal with “satisfaction”. A recent perusal of the Web of Science has shown that EuroIntervention has been referenced in over 150 recent articles published in other peer-review professional journals, with over half of these articles found in such publications as Circulation, JACC, Catheterization and Cardiovascular Interventions, the European Heart Journal, the American Journal of Cardiology, to name just a few of the world renown English language publications where our own journal has been cited. We have also been referenced in the New England Journal of Medicine, not to mention other journals in Spanish, French, German and other languages.

We feel certain, that whatever is happening in these pages, it is being noticed by our community of specialists... and not simply noticed, but taken note of. Our website downloads never cease to astound us, and with this issue, besides the previously mentioned articles on structural heart disease, you will see a range of focus articles, which we are sure will add yet another chapter to our online and print history – surpassing even our current record for downloads.

We are part of the dialogue. We challenge you to follow our lead, join us, and take the lead yourselves in the future. One thing we are certain of... we will be there to publish your results.

Volume 4 Number 2
Aug 20, 2008
Volume 4 Number 2
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-25-00009 Jun 16, 2025
Guideline recommendations for QFR should be revisited: pros and cons
Fearon W and Biscaglia S

Flashlight

10.4244/EIJ-D-24-00795 Jun 16, 2025
Transcaval transcatheter aortic valve implantation via left-sided venous access
Doyle C and Casserly I

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Letter to the editor

10.4244/EIJ-D-25-00197 Jun 16, 2025
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Sticchi A and Biondi-Zoccai G
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved